In the first part of this graduate seminar, we will look at recent and exciting research tackling the problem of antibiotic resistance, including the use of adjuvant and alternatives to antibiotics. The case of Clostridium difficile infection will be examined in particular details. In the second part, we will look at the human gut microbiota in health and diseases, and consider exciting opportunity to target it with therapeutics (drugs, prebiotics, probiotics, fecal microbiota transplantation, etc.). This seminar will involve very recent literature with a special focus on novel therapeutic opportunity. Students will have to present a paper they have selected.

Dr. Bastien Castagner: bastien.castagner@mcgill.ca Schließen